"Both the companies are in talks to co-market the anti-asthmatic drug Xolair in India," said a person with ... Cipla, one of the oldest domestic pharmaceutical companies, is strong in India's Rs 8,500 crore respiratory drug market, with a ...
Read more: Cipla, Novartis explore marketing tie-up